The multi-disciplinary meeting as a tool to identify patients for clinical trials and translational research.Harland S. Winter, David Rea|Journal of Clinical Oncology|2020Cited by 0
WS19.03 Improvements in structural lung disease over 24 months in children with CF aged 6-11 on elexacaftor/tezacaftor/ivacaftor (ETI) – interim analysis using automated LungQ scoringP. McNally, H. Tiddens, M Bönte et al.|Journal of Cystic Fibrosis|2025Cited by 0